New hope for chemo patients: drug may shield nerves from damage
NCT ID NCT07320950
First seen Jan 11, 2026 · Last updated May 19, 2026 · Updated 20 times
Summary
This study tested whether neurotropin can prevent or reduce nerve damage caused by the chemotherapy drug oxaliplatin in people with stage II or III colorectal cancer. A total of 333 adults who had surgery and were about to start chemotherapy took part. The goal was to see if neurotropin could lower the chance of severe nerve problems and help patients complete their full chemo course.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, 510060, China
Conditions
Explore the condition pages connected to this study.